Indegene and Microsoft Collaborate to Advance Generative AI in Life Sciences

Healthcare technology company Indegene announced a partnership with Microsoft to enhance the adoption of Generative AI (GenAI) services among global life sciences firms. This collaboration aims to accelerate innovation on a large scale by developing resources in medical and technology tools to co-innovate GenAI services and workflows across commercial, medical, regulatory, and clinical functions.

Representative image

Advancing Healthcare Technology

According to Indegene CTO Tarun Mathur, "Using GenAI, we're closely working with many of our clients to solve specific business problems, with nearly 50 real-world use cases already in an advanced pilot stage." This highlights the practical applications of GenAI in addressing industry-specific challenges.

Microsoft India & South Asia Chief Operating Officer Alok Lall emphasised the transformative impact of Generative AI on various industries, including life sciences. "Generative AI is profoundly shaping every industry, including life sciences, by offering unprecedented avenues for healthcare technology advancements," he stated.

Integrating Expertise and Technology

The partnership leverages Indegene's domain knowledge alongside Microsoft's Azure OpenAI Service and Microsoft Copilot. This integration positions both companies at the forefront of advancing generative AI within the life sciences sector. Lall noted, "By seamlessly integrating Indegene's domain knowledge with Microsoft Azure OpenAI Service and Microsoft Copilot, we stand at the forefront of advancing generative AI within the life sciences sector."

This collaborative effort aims to empower life sciences companies to fully utilise AI's capabilities. It fosters innovation and scalability within the industry, providing a significant boost to their operational efficiency and effectiveness.

GenAI offers a unique opportunity for life sciences companies to modernise their business processes. It enables them to reimagine the efficiency and effectiveness of their operations throughout the value chain. This technological advancement is seen as a once-in-a-decade chance for substantial improvement in the sector.

In summary, the collaboration between Indegene and Microsoft is set to drive significant advancements in healthcare technology through the adoption of Generative AI. By combining their expertise and resources, they aim to solve specific business problems and foster innovation within the life sciences industry.